Xeinadin acquires three North London practices

Xeinadin has acquired three accountancy practices in North London to strengthen its presence in the capital. The deals involve Evans Mockler in Barnet, Aequitas in Pinner, and AGK Partners in Enfield.

The acquisitions bring more than 80 professionals into the group. The move adds specialist expertise in the construction, pharmacy, and property sectors to Xeinadin’s existing service offering.

Each practice will continue to operate from its current office with existing leadership teams remaining in place. 

The firms will now be supported by Xeinadin’s national infrastructure and technology platforms.

Evans Mockler specialises in property development and investment, while Aequitas focuses on advisory services for community pharmacies. 

AGK Partners has operated for more than 20 years, supporting international tax and audit work.

Derry Crowley, chief executive of Xeinadin, said: “Bringing Evans Mockler, Aequitas, and AGK into Xeinadin strengthens how we support SMEs across North London. Each practice brings established sector expertise and long-standing client relationships, and together they increase the depth of experience available to business owners both locally and nationally.

“Just as importantly, we are investing in talented teams and creating an environment where they can continue to develop with the weight and opportunities of a national practice behind them.”

Martin Mockler, partner at Evans Mockler, added: “We have grown significantly over the last decade and we are proud of the reputation Evans Mockler has built, being accessible, trusted, and consistent in the advice we give. That is something our clients value and something we are committed to maintaining. Being part of Xeinadin allows us to offer even more services, while continuing to operate in the way that has always worked for our clients in the UK and beyond.”

Pankaj Patel, managing director of Aequitas, concluded: “For us, the decision centered on long-term succession and opportunity for our people. Becoming part of Xeinadin provides our team with clearer career progression and access to a wider advisory network, while allowing us to continue delivering the specialist, hands-on support that our pharmacy and cross-industry clients value.”